医学研究与教育 ›› 2014, Vol. 31 ›› Issue (6): 28-30.

• 临床研究 • 上一篇    下一篇

骨髓增殖性肿瘤患者 JAK2V617F 突变和脑血管事件的相关性研究

郭慧梅1,贺建辉2,李云鹏3,尚雪飞3,周云3,宗围3,彭燕3   

  1. 1. 河北大学附属医院血液内科,河北 保定 071000;2. 保定市第一中心医院神经外科,河北 保定 071000;3. 保定市第一医院,河北 保定 071000
  • 出版日期:2014-12-25 发布日期:2014-12-25
  • 通讯作者: 贺建辉(1980—),男,河北保定人,主治医师,硕士,主要从事脑血管疾病的诊治。E-mail: hejianhui2006@163.com
  • 作者简介:郭慧梅(1979—),女,河北邯郸人,主治医师,在读博士,主要从事恶性血液病的研究。E-mail: guohuimei2006@163.com

Study on the correlation of JAK2V617F mutation and cerebrovascular events in patients with myeloproliferative neoplasms

GUO Huimei1, HE Jianhui2, LI Yunpeng3, SHANG Xuefei3, ZHOU Yun3, ZONG Wei3, PENG Yan3   

  1. 1. Department of Hematology, Affiliated Hospital of Hebei University, Baoding 071000, China; 2. Department of Neurosurgery, Baoding First Central Hospital, Baoding 071000, China; 3. The First Hospital of Baoding, Baoding 071000, China
  • Online:2014-12-25 Published:2014-12-25

摘要: 目的 研究骨髓增殖性肿瘤(MPN)患者JAK2V617F突变与脑血管事件的相关性。方法 检测64 例MPN患者 JAK2V617F 突变情况,回顾性分析 64 例 MPN 患者脑血管事件(脑梗死、短暂性脑缺血发作、脑出血、蛛网膜下腔出 血)发生情况等资料,统计分析 JAK2V617F 突变阳性组与阴性组脑血管事件的发生率,并分析 JAK2V617F突变阳性 的不同病种间脑血管事件发生率。结果 64 例 MPN 患者中 47 例(73.4%)存在 JAK2V617F突变,38 例有脑血管事件(59.4%),JAK2V617F 突变阳性和阴性患者中脑血管事件发生率分别为 68.1% 和 35.3%,2 组间 P=0.018。JAK2V617F 突变阳性的PV和ET患者脑血管事件发生率差异无统计学意义。结论 JAK2V617F突变阳性较突变阴性的MPN患者脑血管事件发生的风险可能更高。

关键词: 骨髓增殖性肿瘤, JAK2V617F, 出血, 血栓

Abstract: Objective To investigate the relationship of JAK2V617F mutation and cerebrovascular events in patients with myeloproliferative neoplasms(MPN). Methods The JAK2V617F mutation of 64 patients with MPN was detected. We performed a retrospective study on the incidence of cerebrovascular events(cerebral infarction, transient ischemic attack, cerebral hemorrhage, subarachnoid hemorrhage) in 64 patients with MPN. Statistical analysis was applied on the incidence rate of cerebrovascular events between JAK2V617F mutation positive group and negative group and between groups of different diseases with JAK2V617F mutation. Results Of 64 patients with MPN, JAK2V617F mutation was detected in 47 cases (73.4%). There were a total of 38(59.4%) cerebrovascular events. The incidence rate of cerebrovascular events in JAK2V617F mutation positive and negative patients were 68.1% and 35.3% respectively, P=0.018. The incidence rate between PV and ET patients with JAK2V617F mutation were statistically non-significant. Conclusion The risk of cerebrovascular events in MPN patients with JAK2V617F mutation may be higher.

Key words: myeloproliferative neoplasms, JAK2V617F, hemorrhage, thrombosis

中图分类号: